share_log

26 Analysts Assess Gilead Sciences: What You Need To Know

26 Analysts Assess Gilead Sciences: What You Need To Know

26 位分析師評估吉利德科學:您需要知道的事項
Benzinga ·  00:00
During the last three months, 26 analysts shared their evaluations of Gilead Sciences (NASDAQ:GILD), revealing diverse outlooks from bullish to bearish.
在過去三個月裏,26位分析師對吉利德科學(納斯達克:GILD)分享了他們的評估,展現出從看好到看淡的不同前景。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
以下表格概括了他們最近的評級,展示了過去30天內的情緒演變並與之前的幾個月進行了比較。
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $92.73, with a high estimate of $125.00 and a low estimate of $70.00. This current average has increased by 12.55% from the previous average price target of $82.39.
分析師對12個月價格目標的評估提供了額外的見解,顯示出平均目標爲92.73美元,最高預估爲125.00美元,最低預估爲70.00美元。目前的平均值比之前的平均價格目標82.39美元增加了12.55%。
Deciphering Analyst Ratings: An In-Depth Analysis
分析師評級解讀:深入分析
The standing of Gilead Sciences among financial experts becomes clear...
通過對最近分析師的行...

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論